دورية أكاديمية

Risk of venous thromboembolism after total hip and knee replacement in older adults with comorbidity and co-occurring comorbidities in the Nationwide Inpatient Sample (2003-2006)

التفاصيل البيبلوغرافية
العنوان: Risk of venous thromboembolism after total hip and knee replacement in older adults with comorbidity and co-occurring comorbidities in the Nationwide Inpatient Sample (2003-2006)
المؤلفون: Katz Jeffrey N, Silliman Rebecca A, Segal Jodi B, Winter Michael R, Labonte Alan J, Kapoor Alok, Losina Elena, Berlowitz Dan
المصدر: BMC Geriatrics, Vol 10, Iss 1, p 63 (2010)
بيانات النشر: BMC
سنة النشر: 2010
المجموعة: Directory of Open Access Journals: DOAJ Articles
مصطلحات موضوعية: Geriatrics, RC952-954.6
الوصف: Background Venous thromboembolism is a common, fatal, and costly injury which complicates major surgery in older adults. The American College of Chest Physicians recommends high potency prophylaxis regimens for individuals undergoing total hip or knee replacement (THR or TKR), but surgeons are reluctant to prescribe them due to fear of excess bleeding. Identifying a high risk cohort such as older adults with comorbidities and co-occurring comorbidities who might benefit most from high potency prophylaxis would improve how we currently perform preoperative assessment. Methods Using the Nationwide Inpatient Sample, we identified older adults who underwent THR or TKR in the U.S. between 2003 and 2006. Our outcome was VTE, including any pulmonary embolus or deep venous thrombosis. We performed multivariate logistic regression analyses to assess the effects of comorbidities on VTE occurrence. Comorbidities under consideration included coronary artery disease, congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), diabetes, and cerebrovascular disease. We also examined the impact of co-occurring comorbidities on VTE rates. Results CHF increased odds of VTE in both the THR cohort (OR = 3.08 95% CI 2.05-4.65) and TKR cohort (OR = 2.47 95% CI 1.95-3.14). COPD led to a 50% increase in odds in the TKR cohort (OR = 1.49 95% CI 1.31-1.70). The data did not support synergistic effect of co-occurring comorbidities with respect to VTE occurrence. Conclusions Older adults with CHF undergoing THR or TKR and with COPD undergoing TKR are at increased risk of VTE. If confirmed in other datasets, these older adults may benefit from higher potency prophylaxis.
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 1471-2318
العلاقة: http://www.biomedcentral.com/1471-2318/10/63Test; https://doaj.org/toc/1471-2318Test; https://doaj.org/article/2e0635449c50454db1f8195cce30e27dTest
DOI: 10.1186/1471-2318-10-63
الإتاحة: https://doi.org/10.1186/1471-2318-10-63Test
https://doaj.org/article/2e0635449c50454db1f8195cce30e27dTest
رقم الانضمام: edsbas.618B91F3
قاعدة البيانات: BASE
الوصف
تدمد:14712318
DOI:10.1186/1471-2318-10-63